Wutah pendapatan kuartal marang kuartal: CASI Pharmaceuticals, Inc (CASI)

Simbol lan logo merek CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals commercializes Western oncology drugs in the PRC, minimizing early-stage development risks through licensing. However, the public procurement sector for medicines in China significantly limits business margins. The quarterly revenue growth rate reflects the dynamics of this process, where the value of -60.60 represents the most recent figure. Meanwhile, trade wars and US export restrictions complicate the recognition of medical research.

CASI (casipharmaceuticals.com) riwayat Tingkat wutah dodolan sajrone kuartal saka 04.07.2022 nganti 14.03.2026

Rincian metrik komprehensif lan analitis CASI Pharmaceuticals, Inc (CASI)

- indikator kapitalisasi bursa perusahaan:
Analisis umum perusahaan:CASI Pharmaceuticals, Inc. (CASI)
Produk seri CASI Pharmaceuticals Inc.

CASI Pharmaceuticals monetizes exclusive licenses for Western oncology drugs through an extensive distribution network in China, meaning the quarterly revenue growth rate reflects the actual pace of innovative drug expansion in the Chinese market. The trend of this indicator, calculated as the percentage change in sales of the current quarter compared to the same period last year, allows for the timely detection of operational efficiency stagnation prior to the publication of official financial statements.